Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Elocon vs Fluticasone in Localized Psoriasis (P03197) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing mometasone furoate (Elocon) with fluticasone propionate in localized psoriasis has completed, reporting comparative efficacy and safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elocon (mometasone furoate)
  • Fluticasone (fluticasone propionate)

Snippet

Sponsor: Organon and Co | Conditions: Psoriasis | Phase 4 | Status: COMPLETED